Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavallo

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Immunology|May 1, 1995
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory responseF Cavallo, A Martin-Fontecha, M Bellone, et al.
Medical Education|July 1, 1996
An international comparison of knowledge levels of medical students: the Maastricht Progress TestM G Albano, F Cavallo, R Hoogenboom, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2022
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasisG Avallone, C Cariti, P Dapavo, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Journal of Endocrinological Investigation|May 5, 2010
Carbohydrate counting improves coping ability and metabolic control in patients with Type 1 diabetes managed by Group CareM Trento, A Trinetta, C Kucich, et al.
Contributions to Nephrology|January 1, 1995
Inhibition of experimental IgA nephropathy by colchicineA Amore, L Peruzzi, B Gianoglio, et al.
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
Cancer Research|April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasiaL Cifaldi, E Quaglino, E Di Carlo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4F Pericle, M Giovarelli, M P Colombo, et al.
Human Gene Therapy|June 1, 1995
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growthP L Lollini, C De Giovanni, L Landuzzi, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Immunology|May 1, 1995
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory responseF Cavallo, A Martin-Fontecha, M Bellone, et al.
Medical Education|July 1, 1996
An international comparison of knowledge levels of medical students: the Maastricht Progress TestM G Albano, F Cavallo, R Hoogenboom, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2022
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasisG Avallone, C Cariti, P Dapavo, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Journal of Endocrinological Investigation|May 5, 2010
Carbohydrate counting improves coping ability and metabolic control in patients with Type 1 diabetes managed by Group CareM Trento, A Trinetta, C Kucich, et al.
Contributions to Nephrology|January 1, 1995
Inhibition of experimental IgA nephropathy by colchicineA Amore, L Peruzzi, B Gianoglio, et al.
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
Cancer Research|April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasiaL Cifaldi, E Quaglino, E Di Carlo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4F Pericle, M Giovarelli, M P Colombo, et al.
Human Gene Therapy|June 1, 1995
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growthP L Lollini, C De Giovanni, L Landuzzi, et al.
Pageof 15